Does BOTULINUM TOXIN TYPE A Cause Product use in unapproved indication? 950 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 950 reports of Product use in unapproved indication have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 25.4% of all adverse event reports for BOTULINUM TOXIN TYPE A.
950
Reports of Product use in unapproved indication with BOTULINUM TOXIN TYPE A
25.4%
of all BOTULINUM TOXIN TYPE A reports
475
Deaths
453
Hospitalizations
How Dangerous Is Product use in unapproved indication From BOTULINUM TOXIN TYPE A?
Of the 950 reports, 475 (50.0%) resulted in death, 453 (47.7%) required hospitalization, and 409 (43.1%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 950 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
Gastrooesophageal reflux disease (660)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Product use in unapproved indication Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE